发明名称 Modulators of miR-323-3p for the prevention or treatment of rheumatoid arthritis
摘要 A miR-323-3p inhibitor is provided for the prevention or therapy of rheumatoid arthritis, comprising a sequence capable of forming a hybrid to miR-323-3p as an oligonucleotide or a vector from which such oligonucleotide is transcribed, or as a miRNA decoy or sponge.
申请公布号 US9434944(B2) 申请公布日期 2016.09.06
申请号 US201214241456 申请日期 2012.08.31
申请人 UNIVERSITY OF ZURICH 发明人 Gay Steffen;Connolly Mary;Ospelt Caroline
分类号 C12N15/11;C12N15/113;C07H21/04 主分类号 C12N15/11
代理机构 JMB Davis Ben-David 代理人 JMB Davis Ben-David
主权项 1. A method for treating rheumatoid arthritis in a patient in need thereof, comprising administering to the patient a miR-323-3p inhibitor comprising a hybridizing sequence of nucleotides at least 90% identical to reverse complementary sequence of SEQ ID 1 or SEQ ID 2; thereby treating the rheumatoid arthritis.
地址 Zurich CH